Bharat Biotech, an Indian pharmaceutical company headquartered in Hyderabad, India, has announced the successful completion of a late-stage trial for its oral cholera vaccine, Hillchol. The company plans to launch the vaccine globally, with the goal of producing up to 200 million doses annually. This development comes at a crucial...